- Bruker press release ( NASDAQ: BRKR ): Q2 Non-GAAP EPS of $0.45 misses by $0.12 .
- Revenue of $588.4M (+3.1% Y/Y) misses by $26.99M .
For further details see:
Bruker Non-GAAP EPS of $0.45 misses by $0.12, revenue of $588.4M misses by $26.99MFor further details see:
Bruker Non-GAAP EPS of $0.45 misses by $0.12, revenue of $588.4M misses by $26.99MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
New MBT Pathfinder ® IVD robot for automated MALDI Biotyper ® target preparation New LiquidArray ® MTB-XDR panel for simultaneous detection of M. tuberculosis complex bacteria, and their resistances to five WHO-recommended second-line drugs against multidrug...
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen t...
NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with...